- Corporate Officers - G
- Gosebruch Henry O
Insider Trading History of Gosebruch Henry O
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gosebruch Henry O since 2017.
This trader's CIK number is 1659625.
At the time of last reporting, Gosebruch Henry O was the President & CEO of Neumora Therapeutics, Inc.. (stock ticker symbol NMRA).
Also see all insider trading activities at Neumora Therapeutics, Inc..
Note that in the past
Gosebruch Henry O also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Neumora Therapeutics, Inc. (NMRA) by Gosebruch Henry O
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | NMRA | 15,000 | $189,375 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Acelyrin, Inc. (SLRN) by Gosebruch Henry O
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | SLRN | 50,000 | $900,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aptinyx Inc. (APTX) by Gosebruch Henry O
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | APTX | 25,000 | $75,000 | 0 | $0 | 0 | $0 |
| 2019 | APTX | 100,000 | $385,623 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Abbvie Inc. (ABBV) by Gosebruch Henry O
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | ABBV | 0 | $0 | 123,960 | $18,943,435 | 83,960 | $4,606,045 |
| 2020 | ABBV | 0 | $0 | 40,000 | $3,966,400 | 0 | $0 |
| 2019 | ABBV | 30,000 | $2,018,400 | 0 | $0 | 0 | $0 |
| 2018 | ABBV | 0 | $0 | 42,450 | $3,824,957 | 0 | $0 |
| 2017 | ABBV | 0 | $0 | 36,600 | $2,944,880 | 0 | $0 |
Insider trading activities at 4 companies by Gosebruch Henry O:
1. Neumora Therapeutics, Inc. (NMRA)
2. Acelyrin, Inc. (SLRN)
3. Aptinyx Inc. (APTX)
4. Abbvie Inc. (ABBV)
Table 1. Insider trading of Neumora Therapeutics, Inc. (NMRA) by Gosebruch Henry O
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-09-19 | NMRA | Buy | 15,000 | 12.62 | 189,375 |
Table 2. Insider trading of Acelyrin, Inc. (SLRN) by Gosebruch Henry O
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-05-09 | SLRN | Buy | 50,000 | 18.00 | 900,000 |
Table 3. Insider trading of Aptinyx Inc. (APTX) by Gosebruch Henry O
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-01-10 | APTX | Buy | 25,000 | 3.00 | 75,000 |
| 2019-05-07 | APTX | Buy | 3,420 | 3.75 | 12,825 |
| 2019-05-08 | APTX | Buy | 96,580 | 3.86 | 372,798 |
Table 4. Insider trading of Abbvie Inc. (ABBV) by Gosebruch Henry O
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-05-16 | ABBV | Option Ex | 83,960 | 54.86 | 4,606,045 |
| 2022-05-16 | ABBV | Sale | 83,960 | 155.00 | 13,013,800 |
| 2022-03-01 | ABBV | Sale | 25,000 | 148.12 | 3,703,125 |
| 2022-03-01 | ABBV | Sale | 15,000 | 148.43 | 2,226,510 |
| 2020-11-20 | ABBV | Sale | 40,000 | 99.16 | 3,966,400 |
| 2019-07-29 | ABBV | Buy | 30,000 | 67.28 | 2,018,400 |
| 2018-11-29 | ABBV | Sale | 42,450 | 90.11 | 3,824,957 |
| 2017-10-30 | ABBV | Sale | 18,300 | 90.78 | 1,661,255 |
| 2017-07-31 | ABBV | Sale | 18,000 | 70.14 | 1,262,502 |
| 2017-07-31 | ABBV | Sale | 300 | 70.41 | 21,123 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gosebruch Henry O
(President & CEO of Neumora Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.